文献速递产科母胎医学

评估妊娠期高血压疾病的分析方法

Analytical approaches to evaluating hypertensive disorders of pregnancy.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-11-15

本研究为多中心前瞻性队列研究的二次分析,纳入8011例单胎初产妇,比较两种分析方法下妊娠期高血压疾病(HDP)发生率与分娩孕周的关系。结果发现,在所有持续妊娠中HDP发生率随孕周增加而上升(37周2.0%至41周8.1%),而在各孕周分娩者中HDP发生率随孕周增加而下降(37周24.5%至41周8.1%)。

要点

  • 在所有持续妊娠中,HDP发生率随孕周增加而上升,37周为2.0%,41周为8.1%。
  • 在各孕周分娩者中,HDP发生率随孕周增加而下降,37周为24.5%,41周为8.1%。
  • 研究设计与分析方法对准确解读HDP与分娩孕周关系至关重要。

核心结论

  • 结果证实ARRIVE试验发现,即HDP风险随孕周增加而上升,但HDP在较早孕周分娩者中更常见。
  • 研究设计与分析方法对准确解读结果并应用于临床至关重要。

研究设计与样本

  • 多中心前瞻性队列研究(Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be)的二次分析。
  • 纳入单胎初产妇,分娩孕周≥37+0周;排除未同意数据共享或结局数据缺失者。
  • 最终纳入8011例孕妇。

主要发现

  • 1003例(12.5%)发生HDP;分娩孕周37+0至37+6周者162例(24.5%),38+0至38+6周者232例(18%),39+0至39+6周者310例(12.1%),40+0至40+6周者207例(8.7%),≥41+0周者92例(8.1%)。
  • 分析1:在所有持续妊娠中,HDP发生率随孕周增加而上升(37周2.0%,41周8.1%)。
  • 分析2:在各孕周分娩者中,HDP发生率随孕周增加而下降(37周24.5%,41周8.1%)。

关键数值与推荐

  • HDP定义为妊娠期高血压或子痫前期(伴或不伴严重特征),依据美国妇产科医师学会指南。
  • 分析1:所有持续妊娠中按孕周计算HDP发生率。
  • 分析2:各孕周分娩者中按孕周计算HDP发生率。
  • 假设HDP在足月未进行期待管理。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data from the A Randomized Trial of Induction Versus Expectant Management study suggested that low-risk pregnant patients randomized to expectant management at term had a higher risk for developing hypertensive disorders of pregnancy than pregnant patients randomized to elective induction at 39 weeks. In addition, hypertensive disorders of pregnancy were reported to decrease with advancing gestational age when comparing outcomes by gestational age at delivery. OBJECTIVE: This study aimed to verify these contrasting findings by evaluating the relationship between hypertensive disorders of pregnancy at term and gestational age at delivery. STUDY DESIGN: This was a secondary analysis of a multicenter, prospective cohort study of nulliparous pregnant patients with singleton gestations (from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be). Pregnant patients who delivered ≥37+0 weeks' gestation were included. Patients were excluded if they did not provide consent for data release in subsequent studies or if they had missing outcome data. The primary outcome was hypertensive disorders of pregnancy, defined as gestational hypertension or preeclampsia with or without severe features according to the American College of Obstetricians and Gynecologists guidelines. Descriptive statistics were used to evaluate hypertensive disorders of pregnancy in the following 2 ways: analysis (1), incidence of hypertensive disorders of pregnancy by gestational age week among all ongoing pregnancies and analysis (2), the incidence of hypertensive disorders of pregnancy by gestational age week among deliveries at that gestational age week. It was assumed that hypertensive disorders of pregnancy were not expectantly managed at term. RESULTS: Of the 8011 pregnant patients included in this analysis, 1003 (12.5%) had hypertensive disorders of pregnancy: 162 (24.5%) delivered at 37+0 to 37+6 weeks' gestation, 232 (18%) delivered at 38+0 to 38+6 weeks, 310 (12.1%) delivered at 39+0 to 39+6 weeks, 207 (8.7%) delivered at 40+0 to 40+6 weeks, and 92 (8.1%) delivered at ≥41+0 weeks. In analysis 1, the incidence of hypertensive disorders of pregnancy increased with advancing gestational age among all ongoing pregnancies with a hypertensive disorder of pregnancy (2.0% at 37 weeks and 8.1% at 41 weeks). In analysis 2, the incidence of hypertensive disorders of pregnancy decreased with advancing gestational age among deliveries at that gestational age week alone (24.5% at 37 weeks and 8.1% at 41 weeks). CONCLUSION: Our results confirm the findings from the A Randomized Trial of Induction Versus Expectant Management study showing that the risk for hypertensive disorders of pregnancy increases with advancing gestational age, but hypertensive disorders of pregnancy is more common among deliveries at earlier gestational ages. These key differences illustrate how important the study design and analytical approach are to accurately interpret results and apply findings clinically.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Knupp RJ, Subramaniam A, Tita ANT, et al. Analytical approaches to evaluating hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM. 2022. PMID: 36396039. doi:10.1016/j.ajogmf.2022.100816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。